Navigation Links
Labopharm Reports Results for Second Quarter Fiscal 2009
Date:8/7/2009

>

Research and development expenses, before research and development tax credits, for the second quarter of fiscal 2009 were $3.2 million compared with $7.0 million for the second quarter of fiscal 2008. The decrease was primarily the result of lower clinical trial costs in the second quarter of fiscal 2009. Research and development tax credits for the second quarter of fiscal 2009 were $0.3 million compared with $0.7 million for the second quarter of fiscal 2008, the result of a decrease in non-refundable Canadian federal tax credits due to a change in tax planning.

Selling, general and administrative expenses for the second quarter of fiscal 2009 were $6.3 million compared with $6.2 million for the second quarter of fiscal 2008. A significant portion of selling, general and administrative expenses for the second quarter of fiscal 2009 was the result of higher costs related to sales and marketing and the accrual for the Company's share of litigation costs incurred by Purdue Pharma to enforce certain of Purdue's U.S. patents related to Labopharm's once-daily tramadol product. These were partially offset by lower costs for consultants and professional services, a reduction in non-cash stock-based compensation and a reduction of tax on capital.

Net loss for the second quarter of fiscal 2009 was $4.9 million, or $0.09 per share, compared with $10.3 million, or $0.18 per share, for the second quarter of fiscal 2008. The decrease in net loss was primarily the result of lower research and development costs, higher gross margin on product sales and a higher foreign exchange gain, which were partially offset by lower interest income in the second quarter of fiscal 2009.

Cash, cash equivalents and marketable securities at June 30, 2009 were $27.9 million compared with $35.9 million at March 31, 2009. The cash, cash equivalents and marketable securities position at June 30, 2009 does not include the Company's Long-Term Notes, received in
'/>"/>

SOURCE Labopharm Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Labopharm to present at Canaccord Adams 29th Annual Global Growth Conference
2. Labopharm to host conference call Friday, August 7, 2009 at 8:30 a.m. (ET)
3. Labopharm receives complete response letter from the U.S. FDA for novel antidepressant
4. Labopharm amends debt facility agreement with Hercules
5. Results of phase III study on Labopharms novel antidepressant published in Psychiatry (Edgemont) Journal
6. Labopharm Reports Results for First Quarter Fiscal 2009
7. Labopharm announces details for first quarter results conference call and annual meeting
8. Labopharm reports results for Phase III study on twice-daily tramadol-acetaminophen formulation
9. Labopharm to present at Cowen 29th Annual Health Care Conference
10. Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008
11. Labopharm to host conference call Thursday, February 26, 2009 at 8:30 a.m. (ET)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... ... August 04, 2015 , ... Statement by Paul Gionfriddo, President ... of the Mental Health Reform Act of 2015 by Senators Bill Cassidy ... reform a reality in America. , “This legislation and H.R. 2646 ...
(Date:8/4/2015)... ... 2015 , ... Sponsored by Gila River Casinos, the charity event helps raise ... , According to the New Foundation AZ spokesperson , the organization is still ... a complimentary foursome for the tournament, as well as getting their company advertised on ...
(Date:8/4/2015)... Birmingham, OH (PRWEB) , ... August 04, 2015 ... ... announce that it has joined the American Association of Tissue Banks (AATB) as ... AATB and its mission “to honor donors, and to save and improve lives ...
(Date:8/4/2015)... ... August 04, 2015 , ... Atlantic Health System, one ... to Work® and Fortune among the top five in their list of the 20 ... Morristown, Overlook, Newton and Chilton Medical Centers, Goryeb Children’s Hospital and Atlantic Rehabilitation, is ...
(Date:8/4/2015)... RI (PRWEB) , ... August 04, 2015 , ... Rhode ... imaging center in the George Washington Medical Building on Wake Robin Road in Lincoln, ... the Wake Robin office will offer the most extensive out-patient x-ray hours in the ...
Breaking Medicine News(10 mins):Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 2Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 3Health News:The New Foundation AZ to Host Charity Golf Tournament 2Health News:The New Foundation AZ to Host Charity Golf Tournament 3Health News:Exsurco Medical Joins AATB as Affiliate Member 2Health News:Atlantic Health System Named a 'Best Workplace in Health Care' by Fortune, Great Place to Work® 2Health News:Atlantic Health System Named a 'Best Workplace in Health Care' by Fortune, Great Place to Work® 3Health News:Atlantic Health System Named a 'Best Workplace in Health Care' by Fortune, Great Place to Work® 4Health News:Rhode Island Medical Imaging Opens Satellite Imaging Center on Wake Robin Road in Lincoln 2
... Prediction Accuracy for Lung Cancer, BOSTON, April ... field of molecular diagnostics for lung cancer, has ... diagnosis in the,inaugural edition of Cancer Prevention Research, ... Research (AACR), which is devoted,exclusively to cancer prevention. ...
... tissue navigation systems to expand the $200 million surgical ... to Millennium Research Group, WALTHAM, Mass., April 14, ... Surgical Navigation Systems 2008 report,the surgical navigation market was ... over the next five years. This growth will be ...
... BioElectronics President, CEO, and Chairman Issues Shareholder ... Andrew Whelan,President, CEO and Chairman of BioElectronics, ... FDA-cleared, drug-free anti-inflammatory patch,with an embedded battery ... relieve pain and speed healing, today issued ...
... 14 The rating,agency Standard & Poor,s has raised ... stable". This means that Gerresheimer is now only one,step ... justification for the upgrade, Standard & Poor,s emphasises the,positive ... EBITDA.,Gerresheimer, it says, will be able to sustain this ...
... LaVoie Group, a full-service,provider of public relations, ... science clients, today announced that it has,been selected ... Genetics,(Amex: ILI )., Donna L. LaVoie, ... mind across a number of different constituencies,Interleukin Genetics ...
... "When I,began teaching at the Stark Campus, I knew ... Kathryn Cartechine, assistant professor of,nursing at Kent State University ... the largest Regional Campus of Kent State University expanded,its ... bachelor,s in,nursing, making it one of the 11 undergraduate ...
Cached Medicine News:Health News:Allegro Diagnostics Announces Publication in Cancer Prevention Research of Prediction Model for Lung Cancer Diagnosis Integrating Clinical and Genomic Features 2Health News:Allegro Diagnostics Announces Publication in Cancer Prevention Research of Prediction Model for Lung Cancer Diagnosis Integrating Clinical and Genomic Features 3Health News:New Technology Promises Safer Organ Transplants and Soft Tissue Surgeries 2Health News:New Technology Promises Safer Organ Transplants and Soft Tissue Surgeries 3Health News:BioElectronics CEO Andrew Whelan: Positioning the Company for Growth During 2008 and Beyond 2Health News:BioElectronics CEO Andrew Whelan: Positioning the Company for Growth During 2008 and Beyond 3Health News:BioElectronics CEO Andrew Whelan: Positioning the Company for Growth During 2008 and Beyond 4Health News:Standard & Poor's Raises Gerresheimer Rating to BB+ 2Health News:LaVoie Group Adds Interleukin Genetics to its Life Science Agency Roster 2Health News:Kent State University Stark Campus to Confer First Class of Nursing Students 2
(Date:8/5/2015)...  Butterfly Network was awarded today as one ... for 2015.  The company is democratizing medical imaging ... By integrating its novel imaging platform with deep ... virtuous cycle, learning as they image, and continually ... chosen by a professional jury among hundreds of ...
(Date:8/4/2015)... and SOUTHAMPTON , ... company Pharmaxis Ltd (ASX: PXS) and UK biotechnology company Synairgen ... research collaboration to develop a selective inhibitor to the lysyl ... disease idiopathic pulmonary fibrosis (IPF). IPF affects ... products are expected to produce global revenues in excess of ...
(Date:8/4/2015)... , Aug. 4, 2015  Eli Lilly and ... of California, San Diego (UCSD) of its intent to ... of the Anti-amyloid Treatment in Asymptomatic Alzheimer,s disease (A4) ... testing solanezumab in the preclinical stage of Alzheimer,s disease ... their brains on a PET scan, but do not ...
Breaking Medicine Technology:Butterfly Network Recognized as a Technology Pioneer by the World Economic Forum 2Pharmaxis and Synairgen Announce Research Collaboration to Develop LOXL2 Inhibitor For Pulmonary Fibrosis 2Pharmaxis and Synairgen Announce Research Collaboration to Develop LOXL2 Inhibitor For Pulmonary Fibrosis 3Lilly to End Contract with the University of California, San Diego for A4 Alzheimer's Study 2Lilly to End Contract with the University of California, San Diego for A4 Alzheimer's Study 3
... PXS; Nasdaq: PXSL) today announced that the company ... reached agreement on the phase 3,registration trial of ... The SPA process allows for FDA evaluation ... primary basis of an efficacy claim in support ...
... 19 The Australian company Fermiscan,who is using ... new breast cancer,screening test through the analysis of ... 69% in detecting breast cancer., (Photo: ... the Journal of the American Medical,Association(1) (US study), ...
Cached Medicine Technology:Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial 2Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial 3New Australian Technology: Detecting Breast Cancer With Hair 2New Australian Technology: Detecting Breast Cancer With Hair 3New Australian Technology: Detecting Breast Cancer With Hair 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: